- Home
- XTKG vs IRIX Comparison
XTKG vs IRIX Comparison
Compare XTKG & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTKG
- IRIX
- Stock Information
- Founded
- XTKG 1997
- IRIX 1989
- Country
- XTKG Singapore
- IRIX United States
- Employees
- XTKG N/A
- IRIX N/A
- Industry
- XTKG
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XTKG
- IRIX Health Care
- Exchange
- XTKG NYSE
- IRIX Nasdaq
- Market Cap
- XTKG 16.3M
- IRIX 16.5M
- IPO Year
- XTKG 2019
- IRIX 1996
- Fundamental
- Price
- XTKG $1.55
- IRIX $0.88
- Analyst Decision
- XTKG
- IRIX
- Analyst Count
- XTKG 0
- IRIX 0
- Target Price
- XTKG N/A
- IRIX N/A
- AVG Volume (30 Days)
- XTKG 106.9K
- IRIX 68.0K
- Earning Date
- XTKG 07-07-2025
- IRIX 08-07-2025
- Dividend Yield
- XTKG N/A
- IRIX N/A
- EPS Growth
- XTKG N/A
- IRIX N/A
- EPS
- XTKG N/A
- IRIX N/A
- Revenue
- XTKG $11,611,442.00
- IRIX $48,804,000.00
- Revenue This Year
- XTKG N/A
- IRIX $9.61
- Revenue Next Year
- XTKG N/A
- IRIX N/A
- P/E Ratio
- XTKG N/A
- IRIX N/A
- Revenue Growth
- XTKG N/A
- IRIX N/A
- 52 Week Low
- XTKG $0.53
- IRIX $0.78
- 52 Week High
- XTKG $11.60
- IRIX $2.41
- Technical
- Relative Strength Index (RSI)
- XTKG 49.51
- IRIX 37.02
- Support Level
- XTKG $1.36
- IRIX $0.92
- Resistance Level
- XTKG $2.24
- IRIX $1.00
- Average True Range (ATR)
- XTKG 0.23
- IRIX 0.04
- MACD
- XTKG -0.03
- IRIX -0.00
- Stochastic Oscillator
- XTKG 22.22
- IRIX 12.38
About XTKG X3 HOLDINGS CO LTD
X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries. It generates revenue from service lines: Application development services; Consulting and technical support services; Subscription services; Trading; and Others, of which maximum revenue is derived from Application development services. Geographically, all of the company's revenue is derived from PRC.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.